Text Size

Consensus Recommendations for Studies of Outflow Facility and Intraocular Pressure Regulation Using Ex Vivo Perfusion Approaches

Acott T.S.; Fautsch M.P.; Mao W.; Ethier C.R.; Huang A.S.; Kelley M.J.; Aga M.; Bhattacharya S.K.; Borras T.; Bovenkamp D.; Chowdhury U.R.; Clark A.F.; Dibas M.I.; Du Y.; Elliott M.H.; Faralli J.A.; Gong H.; Herberg S.; Johnstone M.A.; Kaufman P.L.; Keller K.E.; Kelly R.A.; Krizaj D.; Kuehn M.H.; Li H.L.; Lieberman R.; Lin S.C.; Liu Y.; McDonnell F.S.; McDowell C.M.; McLellan G.J.; Mzyk P.; Nair K.S.; Overby D.R.; Peters D.M.; Raghunathan V.; Rao P.V.; Roddy G.W.; Sharif N.A.; Shim M.S.; Sun Y.; Thomson B.R.; Toris C.B.; Willoughby C.E.; Zhang H.F.; Freddo T.F.; Fuchshofer R.; Hill K.R.; Karimi A.; Kizhatil K.; Kopcyznski C.C.; Liton P.; Patel G.; Peng M.; Pattabiraman P.P.; Prasanna G.; Reina-Torres E.; Samples E.G.; Samples J.R.; Steel C.L.; Strohmaier C.A.; Subramanian P.; Sugali C.K.; van Batenburg-Sherwood J.; Wong C.; Youngblood H.; Zode G.S.; White E.; Stamer W.D.


  • 2024
  • Investigative Ophthalmology and Visual Science
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Oregon, Portland, United States; Department of Ophthalmology, Mayo Clinic, Rochester, MN, United States; Department of Ophthalmology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, United States; Departments of Biochemistry and Molecular Biology and Pharmacology and Toxicology, Eugene and Marilyn Glick Eye Institute, Indiana University School of Medicine, Indianapolis, IN, United States; Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, GA, United States; Hamilton Glaucoma Center, The Viterbi Family Department of Ophthalmology, Shiley Eye Institute, University of California, San Diego, CA, United States; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Florida, United States; University of North Carolina, Chapel Hill, NC, United States; BrightFocus Foundation, Clarksburg, MD, United States; North Texas Eye Research Institute, University of North Texas Health Science Center, Fort Worth, TX, United States; Glaucoma Research, Ophthalmology Discovery, AbbVie, Irvine, CA, United States; Morsani College of Medicine, University of South Florida, Tampa, FL, United States; Department of Ophthalmology and Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States; Department of Pathology and Laboratory Medicine, School of Medicine and Public Health, University of Wisconsin–Madison, Wisconsin, Madison, United States; Department of Ophthalmology, Boston University School of Medicine, Boston, MA, United States; Department of Ophthalmology & Visual Sciences, SUNY Upstate Medical University, Syracuse, NY, United States; Department of Ophthalmology, University of Washington, Seattle, WA, United States; Department of Ophthalmology and Visual Sciences, University of Wisconsin–Madison, Madison, WI, United States; Department of Ophthalmology, Duke University, Durham, NC, United States; Department of Biomedical Engineering, Duke University, Durham, NC, United States; Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, UT, United States; Department Ophthalmology and Visual Sciences, Iowa City VA Center for Prevention and Treatment of Visual Loss, University of Iowa, Iowa City, IA, United States; School of Chemistry and Biochemistry, Georgia Institute of Technology, Atlanta, GA, United States; Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta University, Augusta, GA, United States; John Moran Eye Center, University of Utah, Salt Lake City, UT, United States; Department of Surgical Sciences, School of Veterinary Medicine, University of Wisconsin–Madison, Madison, WI, United States; Deptartment of Ophthalmology, University of California, San Francisco, San Francisco, CA, United States; Department of Bioengineering, Imperial College of London, London, United Kingdom; Department of Ophthalmology, Novartis Institutes for BioMedical Research, Cambridge, MA, United States; Department of Pharmacology and Cancer Biology, Duke University School of Medicine, Durham, NC, United States; Global Alliances and Collaborations, Ophthalmology Innovation Center, Santen Inc., Emeryville, CA, United States; Department of Ophthalmology, Stanford University School of Medicine, Palo Alto, CA, United States; Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States; Department of Ophthalmology and Visual Sciences, Ohio State University Wexner Medical Center, Columbus, OH, United States; Genomic Medicine, Biomedical Sciences Research Institute, Ulster University, Northern Ireland, Coleraine, United Kingdom; Department of Biomedical Engineering, Northwestern University, Evanston, IL, United States; MCP Health Sciences University, Westport, MA, United States; Institute for Human Anatomy and Embryology, University of Regensburg, Regensburg, Germany; Department of Ophthalmology and Visual Science, Ohio State University, Columbus, OH, United States; Aerie Pharmaceuticals, Inc., Durham, NC, United States; Department of Ophthalmology and Genetics Medicine Research, Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States; Western Glaucoma Foundation, Olympia, WA, United States; Washington State College of Medicine, Spokane, WA, United States; Qlaris Bio, Inc., Wellesley, MA, United States; Department of Ophthalmology and Optometry, Kepler University Hospital, Johannes Kepler University, Linz, Austria; Department of Ophthalmology, University of California at Irvine, Irvine, CA, United States

Related Publications

Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats

Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.


A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension

Konstas A.G.; Garhöfer G.; Lübke Y.; Voykov B.; Ropo A.


Valproic Acid Application to Modify Post Surgical Fibrosis in a Model of Minimally Invasive Bleb Surgery

Lo P.F.; Gunawan M.; Yap Z.L.; Leong C.; Kwek F.; Varadarajan J.; Wang X.; Kageyama M.; Wong T.T.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022